Theracryf Plc (AIM:TCF)
London · Delayed Price · Currency is GBP · Price in GBX 0.2300
-0.0100 (-4.17%)
Aug 8, 2025, 9:26 AM GMT+1
Theracryf Market Cap
Theracryf has a market cap or net worth of 5.11 million as of August 8, 2025. Its market cap has increased by 54.32% in one year.
Market Cap
5.11M
Enterprise Value
997.09K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.23
Market Cap Chart
Since October 21, 2015, Theracryf's market cap has decreased from 25.60M to 5.11M, a decrease of -80.03%. That is a compound annual growth rate of -15.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 5.11M | 126.60% |
| Dec 31, 2024 | 2.26M | -48.72% |
| Dec 29, 2023 | 4.40M | -64.04% |
| Dec 30, 2022 | 12.23M | -13.59% |
| Dec 31, 2021 | 14.16M | -0.45% |
| Dec 31, 2020 | 14.22M | 51.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Oct 21, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.41B |
| GSK plc | 56.36B |
| Haleon | 31.43B |
| Smith & Nephew | 11.70B |
| ConvaTec Group | 4.61B |
| Hikma Pharmaceuticals | 4.15B |
| HUTCHMED (China) | 2.23B |
| Oxford Nanopore Technologies | 2.06B |